---
document_datetime: 2024-02-13 11:40:55
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/vueway-epar-all-authorised-presentations_en.pdf
document_name: vueway-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 3.3956016
conversion_datetime: 2025-12-21 17:48:18.252088
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength            | Pharmaceutical Form              | Route of Administration   | Immediate Packaging     | Content (concentration)   | Pack size                                                                                                                    |
|------------------|-------------------|---------------------|----------------------------------|---------------------------|-------------------------|---------------------------|------------------------------------------------------------------------------------------------------------------------------|
| EU/1/23/1773/001 | Vueway            | 0.5 mmol/ml         | Solution for injection           | Intravenous use           | vial (glass)            | 3 ml                      | 1 vial                                                                                                                       |
| EU/1/23/1773/002 | Vueway            | 0.5 mmol/ml         | Solution for injection           | Intravenous use           | vial (glass)            | 7.5 ml                    | 1 vial                                                                                                                       |
| EU/1/23/1773/003 | Vueway            | 0.5 mmol/ml         | Solution for injection           | Intravenous use           | vial (glass)            | 7.5 ml                    | 25 vials                                                                                                                     |
| EU/1/23/1773/004 | Vueway            | 0.5 mmol/ml         | Solution for injection           | Intravenous use           | vial (glass)            | 10 ml                     | 1 vial                                                                                                                       |
| EU/1/23/1773/005 | Vueway            | 0.5 mmol/ml         | Solution for injection           | Intravenous use           | vial (glass)            | 10 ml                     | 25 vials                                                                                                                     |
| EU/1/23/1773/006 | Vueway            | 0.5 mmol/ml         | Solution for injection           | Intravenous use           | vial (glass)            | 15 ml                     | 1 vial                                                                                                                       |
| EU/1/23/1773/007 | Vueway            | 0.5 mmol/ml         | Solution for injection           | Intravenous use           | vial (glass)            | 15 ml                     | 25 vials                                                                                                                     |
| EU/1/23/1773/008 | Vueway            | 0.5                 | Solution for                     | Intravenous use           | vial (glass)            | 30 ml                     | 1 vial                                                                                                                       |
| EU/1/23/1773/009 | Vueway            | mmol/ml 0.5 mmol/ml | injection Solution for injection | Intravenous use           | vial (glass)            | 50 ml                     | 1 vial                                                                                                                       |
| EU/1/23/1773/010 | Vueway            | 0.5                 | Solution for                     | Intravenous use           | vial (glass)            | 100 ml                    | 1 vial                                                                                                                       |
| EU/1/23/1773/011 | Vueway            | 0.5 mmol/ml         | Solution for injection           | Intravenous use           | pre-filled syringe (PP) | 7.5 ml                    | 1 pre-filled syringe                                                                                                         |
| EU/1/23/1773/012 | Vueway            | 0.5 mmol/ml         | Solution for injection           | Intravenous use           | pre-filled syringe (PP) | 7.5 ml                    | 10 (10 x 1) pre- filled syringes (multipack)                                                                                 |
| EU/1/23/1773/013 | Vueway            | 0.5 mmol/ml         | Solution for injection           | Intravenous use           | pre-filled syringe (PP) | 7.5 ml                    | 1 pre-filled syringe + 1 administration set for manual injection (1 extension line + 1                                       |
| EU/1/23/1773/014 | Vueway            | 0.5 mmol/ml         | Solution for injection           | Intravenous use           | pre-filled syringe (PP) | 7.5 ml                    | 1 pre-filled syringe + 1 administration set for Optistar Elite injector (1 extension line + 1 catheter + 1 syringe of 60 ml) |

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name   | Strength    | Pharmaceutical Form    | Route of Administration   | Immediate Packaging     | Content (concentration)   | Pack size                                                                                                                                 |
|------------------|-------------------|-------------|------------------------|---------------------------|-------------------------|---------------------------|-------------------------------------------------------------------------------------------------------------------------------------------|
| EU/1/23/1773/015 | Vueway            | 0.5 mmol/ml | Solution for injection | Intravenous use           | pre-filled syringe (PP) | 7.5 ml                    | 1 pre-filled syringe + 1 administration set for Medrad Spectris Solaris EP injector (1 extension line + 1 catheter + 1 syringe of 115 ml) |
| EU/1/23/1773/016 | Vueway            | 0.5 mmol/ml | Solution for injection | Intravenous use           | pre-filled syringe (PP) | 10 ml                     | 1 pre-filled syringe                                                                                                                      |
| EU/1/23/1773/017 | Vueway            | 0.5 mmol/ml | Solution for injection | Intravenous use           | pre-filled syringe (PP) | 10 ml                     | 10 (10 x 1) pre- filled syringes (multipack)                                                                                              |
| EU/1/23/1773/018 | Vueway            | 0.5 mmol/ml | Solution for injection | Intravenous use           | pre-filled syringe (PP) | 10 ml                     | 1 pre-filled syringe + 1 administration set for manual injection (1 extension line + 1                                                    |
| EU/1/23/1773/019 | Vueway            | 0.5 mmol/ml | Solution for injection | Intravenous use           | pre-filled syringe (PP) | 10 ml                     | 1 pre-filled syringe + 1 administration set for Optistar Elite injector (1 extension line + 1 catheter + 1 syringe of 60 ml)              |
| EU/1/23/1773/020 | Vueway            | 0.5 mmol/ml | Solution for injection | Intravenous use           | pre-filled syringe (PP) | 10 ml                     | 1 pre-filled syringe + 1 administration set for Medrad Spectris Solaris EP injector (1 extension line + 1 catheter + 1                    |
| EU/1/23/1773/021 | Vueway            | 0.5 mmol/ml | Solution for injection | Intravenous use           | pre-filled syringe (PP) | 15 ml                     | 1 pre-filled syringe                                                                                                                      |

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name   | Strength    | Pharmaceutical Form    | Route of Administration   | Immediate Packaging     | Content (concentration)   | Pack size                                                                                                                                 |
|------------------|-------------------|-------------|------------------------|---------------------------|-------------------------|---------------------------|-------------------------------------------------------------------------------------------------------------------------------------------|
| EU/1/23/1773/022 | Vueway            | 0.5 mmol/ml | Solution for injection | Intravenous use           | pre-filled syringe (PP) | 15 ml                     | 10 (10 x 1) pre- filled syringes (multipack)                                                                                              |
| EU/1/23/1773/023 | Vueway            | 0.5 mmol/ml | Solution for injection | Intravenous use           | pre-filled syringe (PP) | 15 ml                     | 1 pre-filled syringe + 1 administration set for manual injection (1 extension line + 1 catheter)                                          |
| EU/1/23/1773/024 | Vueway            | 0.5 mmol/ml | Solution for injection | Intravenous use           | pre-filled syringe (PP) | 15 ml                     | 1 pre-filled syringe + 1 administration set for Optistar Elite injector (1 extension line + 1 catheter + 1                                |
| EU/1/23/1773/025 | Vueway            | 0.5 mmol/ml | Solution for injection | Intravenous use           | pre-filled syringe (PP) | 15 ml                     | 1 pre-filled syringe + 1 administration set for Medrad Spectris Solaris EP injector (1 extension line + 1 catheter + 1 syringe of 115 ml) |